Epilepsy Action news

Brexit update - January 2021

18 January 2021 What’s happened?

As of 1 January 2021 the United Kingdom (UK) formally left the European Union (EU). In December...

Read more

Brexit in the new Parliament - January 2020

21 January 2020 What's happened?

Since the December 2019 General Election, the Government has been working to formalise the UK's...

Read more

What does the final NICE recommendation on cannabidiol/ CBD (Epidyolex) mean for people with epilepsy?

13 November 2019 What's happened?

The National Institute for Health and Care Excellence (NICE) has recommended Epidyolex, a purified...

Read more

12 months since the law change on medicinal cannabis – where are we now?

01 November 2019

It has been a year since the law changed to allow specialist doctors to prescribe cannabis-based medicines. But what...

Read more

Update on no-deal preparations

18 September 2019 What’s new?

September 2019 saw the publication of the government’s ‘Operation Yellowhammer’ document. This sets out...

Read more

Brexit and epilepsy – where are we now?

14 August 2019

The recent change of Prime Minister in the UK is relevant to people with epilepsy for many reasons. One of the most...

Read more

What does the draft NICE cannabis-based medicines guidance mean for people with epilepsy?

12 August 2019 What is the draft NICE cannabis-based medicines guidance?

The National Institute for Health and Care Excellence (...

Read more

Thank you!

26 June 2019

We know that heading out and about can be worrying if there’s a chance you’ll have a seizure in a public place....

Read more

Epilepsy Action Northern Ireland Community Arts Partnership

16 April 2019

How would you describe the journey your epilepsy has taken you on? A group of people in Northern Ireland have been...

Read more


Subscribe to the e-action newsletter

Stay up to date with the latest news on coronavirus, epilepsy news and events, and how you can get involved.

Epilepsy Action will never swap, share or sell your details. For more information, read our privacy policy.
By clicking subscribe you agree to our privacy policy.